(MedPage Today) -- Two surrogate markers commonly used in multiple sclerosis clinical trials are near-perfect measures of the effect of treatment with interferon, researchers reported...

MS Markers Match Disability Progression (CME/CE) (click here for the full article at MedPage Today)